TIGIT inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TIGIT inhibitor, covering 2025-10-09 to 2025-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial Carcinoma [Phase 1, Phase 2]